Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 75 mg - capsule, hard - excipient ingredients: purified water; sodium lauryl sulfate; pregelatinised maize starch; titanium dioxide; gelatin; iron oxide red; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyraccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyraccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 25 mg - capsule, hard - excipient ingredients: gelatin; titanium dioxide; sodium lauryl sulfate; purified water; pregelatinised maize starch; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyraccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyraccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 150 mg - capsule, hard - excipient ingredients: purified water; purified talc; gelatin; titanium dioxide; sodium lauryl sulfate; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyraccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyraccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 25 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; gelatin; titanium dioxide; purified water; pregelatinised maize starch; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyraccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyraccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 300 mg - capsule, hard - excipient ingredients: gelatin; iron oxide red; purified talc; purified water; pregelatinised maize starch; sodium lauryl sulfate; titanium dioxide; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyraccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyraccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 75 mg - capsule, hard - excipient ingredients: gelatin; iron oxide red; sodium lauryl sulfate; pregelatinised maize starch; purified water; titanium dioxide; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyraccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyraccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 300 mg - capsule, hard - excipient ingredients: gelatin; purified talc; sodium lauryl sulfate; purified water; pregelatinised maize starch; titanium dioxide; iron oxide red; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyraccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyraccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 150 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; purified water; purified talc; titanium dioxide; gelatin; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyraccord (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyraccord (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levetiracetam, quantity: 1000 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; povidone; magnesium stearate; croscarmellose sodium; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - ketraccord tablets are indicated for: ? use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. ? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. ? add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme) and, ? add-on therapy in the treatment of primary generalised tonic-clonic seizures (pgtc) in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levetiracetam, quantity: 500 mg - tablet, film coated - excipient ingredients: povidone; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - ketraccord tablets are indicated for: ? use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. ? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. ? add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme) and, ? add-on therapy in the treatment of primary generalised tonic-clonic seizures (pgtc) in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).